These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3396415)

  • 1. Cardiopulmonary effects of enprofylline. A xanthine with weak adenosine receptor antagonism in patients with severe chronic lung disease.
    Vik-Mo H; Gulsvik A; Folling M
    Chest; 1988 Aug; 94(2):354-9. PubMed ID: 3396415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects of enprofylline and theophylline.
    Esquivel M; Burns RJ; Ogilvie RI
    Clin Pharmacol Ther; 1986 Apr; 39(4):395-402. PubMed ID: 3956056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of safer xanthine drugs for treatment of obstructive airways disease.
    Persson CG
    J Allergy Clin Immunol; 1986 Oct; 78(4 Pt 2):817-24. PubMed ID: 3534062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive inotropic and chronotropic effects and coronary vasodilation in vitro by two antiasthmatic xanthines with different abilities to antagonize adenosine.
    Persson CG; Erjefält I; Andersson KE
    J Cardiovasc Pharmacol; 1983; 5(5):778-85. PubMed ID: 6195465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between theophylline and an adenosine non-blocking xanthine in acute asthma.
    Vilsvik JS; Persson CG; Amundsen T; Brenna E; Naustdal T; Syvertsen U; Storstein L; Källén AG; Eriksson G; Holte S
    Eur Respir J; 1990 Jan; 3(1):27-32. PubMed ID: 2311727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of enprofylline, a xanthine lacking adenosine receptor antagonism, in patients with chronic obstructive lung disease.
    Lunell E; Svedmyr N; Andersson KE; Persson CG
    Eur J Clin Pharmacol; 1982; 22(5):395-402. PubMed ID: 6288396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of two xanthines and the relation to adenosine antagonism.
    Smits P; Schouten J; Thien T
    Clin Pharmacol Ther; 1989 Jun; 45(6):593-9. PubMed ID: 2659234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of adenosine and xanthine derivatives on breathing during acute hypoxia in the anesthetized newborn piglet.
    Darnall RA; Bruce RD
    Pediatr Pulmonol; 1987; 3(2):110-6. PubMed ID: 3588054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasting effects of two xanthines, theophylline and enprofylline, on the cardio-respiratory stimulation of infused adenosine in man.
    Maxwell DL; Fuller RW; Conradson TB; Dixon CM; Aber V; Hughes JM; Barnes PJ
    Acta Physiol Scand; 1987 Nov; 131(3):459-65. PubMed ID: 3425350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics and pharmacokinetics of enprofylline and theophylline in the isolated rabbit heart.
    Nielsen-Kudsk JE; Askholt J
    Pharmacol Toxicol; 1988 Sep; 63(3):183-8. PubMed ID: 3186628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiological aspects of predominant preload lowering on pulmonary circulation, gas exchange, and the biventricular function in patients with chronic obstructive lung disease.
    Seibold H; Bunjes D; Schmidt A; Hombach V
    Clin Cardiol; 1988 Sep; 11(9):630-8. PubMed ID: 3229018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance and some circulatory effects of intravenous and oral enprofylline in healthy volunteers.
    Lunell E; Andersson KE; Persson CG
    Acta Pharmacol Toxicol (Copenh); 1983 Sep; 53(3):205-11. PubMed ID: 6637510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous enprofylline in asthma patients.
    Lunell E; Andersson KE; Persson CG; Svedmyr N
    Eur J Respir Dis; 1984 Jan; 65(1):28-34. PubMed ID: 6705855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac arrhythmias in patients with mild-to-moderate obstructive lung disease. Comparison of beta-agonist therapy alone and in combination with a xanthine derivative, enprofylline or theophylline.
    Conradson TB; Eklundh G; Olofsson B; Pahlm O; Persson G
    Chest; 1985 Oct; 88(4):537-42. PubMed ID: 2864221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel bronchodilator xanthine apparently without adenosine receptor antagonism and tremorogenic effect.
    Lunell E; Svedmyr N; Andersson KE; Persson CG
    Eur J Respir Dis; 1983 Jul; 64(5):333-9. PubMed ID: 6309542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of indomethacin on pulmonary hemodynamics and gas exchange in patients with pulmonary artery hypertension, interference with hydralazine.
    Adnot S; Defouilloy C; Brun-Buisson C; Piquet J; de Cremoux H; Lemaire F
    Am Rev Respir Dis; 1987 Dec; 136(6):1343-9. PubMed ID: 3688636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic and gas exchange responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension.
    Adnot S; Kouyoumdjian C; Defouilloy C; Andrivet P; Sediame S; Herigault R; Fratacci MD
    Am Rev Respir Dis; 1993 Aug; 148(2):310-6. PubMed ID: 8342892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deleterious effect of nifedipine on pulmonary gas exchange in chronic obstructive pulmonary disease.
    Melot C; Hallemans R; Naeije R; Mols P; Lejeune P
    Am Rev Respir Dis; 1984 Oct; 130(4):612-6. PubMed ID: 6091508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory actions of enprofylline, a modified xanthine, in the canine forelimb.
    Dobbins DE; Soika CY; Buehn MJ; Dabney JM
    Circ Res; 1989 Feb; 64(2):235-42. PubMed ID: 2563237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enprofylline--effects of a new bronchodilating xanthine derivative in asthmatic patients.
    Laursen LC; Johannesson N; Dirksen A; Djurup R; Munch EP; Taudorf E; Weeke B
    Allergy; 1983 Jan; 38(1):75-9. PubMed ID: 6340552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.